These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3920845)
1. [Obtaining antisera to Pseudomonas aeruginosa and Proteus antigens for performing immunoenzyme analyses in clinical practice]. Bulava GV; Ermolin GA Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):51-5. PubMed ID: 3920845 [TBL] [Abstract][Full Text] [Related]
2. [Immunoenzyme method of diagnosing suppurative-septic complications due to Pseudomonas aeruginosa and Proteus]. Bulava GV; Ermolin GA; Grigor'ev NI Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):89-93. PubMed ID: 6431720 [TBL] [Abstract][Full Text] [Related]
3. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum]. Podgornaia LG; Dziuban NF Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510 [TBL] [Abstract][Full Text] [Related]
4. [Preventive properties of the blood sera from persons vaccinated with a Proteus vaccine made from soluble antigen complexes]. Levina LA; Kreĭnin LS; Kaverina KG; Zdanovskaia LK; Iurova VA Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):84-8. PubMed ID: 3087123 [TBL] [Abstract][Full Text] [Related]
5. Effect of active and passive antibacterial immunization on skin allograft survival in rabbits. Liska M; Hatala M Folia Biol (Praha); 1979; 25(1):70-5. PubMed ID: 107050 [TBL] [Abstract][Full Text] [Related]
6. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. Senior BW; McBride PD; Morley KD; Kerr MA J Med Microbiol; 1995 Sep; 43(3):176-84. PubMed ID: 7650724 [TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa and Proteus antigenemia and antibody formation in mono- and mixed infections in patients with suppurative inflammatory diseases]. Bulava GV; Men'shikov DD; Khvatov VB Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):63-7. PubMed ID: 3107287 [TBL] [Abstract][Full Text] [Related]
8. [Studies on the specificity of antisera against denaturated desoxyribonucleic acids]. Störl HJ; Simon H; Barthelmes H Acta Biol Med Ger; 1974; 33(4):485-95. PubMed ID: 4219522 [No Abstract] [Full Text] [Related]
9. [Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. The toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections]. Kreĭnin LS; Egorova NB; Stanislavskiĭ ES; Kaverina KG; Levina LA Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):87-92. PubMed ID: 6410625 [TBL] [Abstract][Full Text] [Related]
10. [Protective properties of antigenic complexes of Proteus]. Kreĭnin LS; Kaverina KG; Aksenova EV; Buatkova LIu Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):60-4. PubMed ID: 7015763 [TBL] [Abstract][Full Text] [Related]
11. [Preparation of Pseudomonas aeruginosa recombinant outer-membrane protein F and the study of its antigenic properties]. Kaloshin AA; Zlygostev SA; Toropchina IuN; Kurbatova EA; Zverev VV; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):50-3. PubMed ID: 16279535 [TBL] [Abstract][Full Text] [Related]
13. [Use of an immunoenzyme method for detecting specific antibodies to Pseudomonas aeruginosa in patients with acute and chronic lung diseases]. Dubeĭkovskaia ZA; Savitskaia KI; Antsiferova NG; Shakhanina KL; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):53-7. PubMed ID: 6415971 [TBL] [Abstract][Full Text] [Related]
14. [Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime]. Aleksandrova IA; Moroz AF; Antsiferova NG; Aleksandrov AD Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):72-5. PubMed ID: 3099518 [TBL] [Abstract][Full Text] [Related]
15. Protection against Gram-negative infection by 'super-active' antigen. Roe EA Immunology; 1976 Nov; 31(5):707-15. PubMed ID: 825449 [TBL] [Abstract][Full Text] [Related]
16. [Serodiagnosis and immunological aspects of Proteus infection. III. Immunological, bacteriological and pathomorphological parallels in experimental Proteus intestinal infections, mono- and mixed]. Bidnenko SI; Bernasovskaia EP; Barshteĭn IuA; Ganziĭ GP Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):105-10. PubMed ID: 6758428 [TBL] [Abstract][Full Text] [Related]
17. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4]. Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515 [TBL] [Abstract][Full Text] [Related]
18. [Basis for the potential production of immune preparations against Pseudomonas aeruginosa from the blood of convalescent burn patients]. Povstianoĭ NE; Kolker II; Nazarchuk LV; Fedorovskaia EA; Litovchenko PP Gematol Transfuziol; 1984 Jul; 29(7):56-8. PubMed ID: 6205938 [No Abstract] [Full Text] [Related]
19. [Obtaining of outer membrane protein I of Pseudomonas aeruginosa and assessment of its antigenic properties]. Gatypova EV; Zlygostev SA; Kaloshin AA; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):50-3. PubMed ID: 19189463 [TBL] [Abstract][Full Text] [Related]
20. [Production of a hyperimmune antitoxic donor plasma against Pseudomonas aeruginosa]. Krokhina MA; Davatdarova GM; Cherkas GP; Podgornaia LG; Shinkarenko AA Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):78-83. PubMed ID: 6778040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]